An official website of the United States government
Home
Name
Acapodene
Alternate Names
FC-1157a
Toremifene
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
Gene therapy
NSC Number
None
Primary Site
Prostate cancer
Histology
None
Remarks
Phase II Chemoprevention, gene therapy. FDA approved use on advanced breast cancer. Genotherapeutics. Promotes retargeted cytotoxicity against HER2/neu-positive cell lines.
Coding
This drug should be coded
